Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.
Also called NCT05047198
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 244 participants
- Registry
-
NCT05047198
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05047198. Randomized; no masking; primary purpose treatment. Start 2022-12-06 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
- Acronym
- CARA-VT RCT
- Condition
- Ventricular Tachycardia
- Intervention (Procedure)
- Control - Catheter Ablation for VT
- Intervention (Procedure)
- Treatment - Non-Invasive Radio Ablation for VT
- Lead sponsor
- Ottawa Heart Institute Research Corporation
Record details
- Record id
cardio:ct-nct05047198- Content hash
050830ceed5eaa4e85fdc67e7eae3028c96e3a99b1e36ab7c83438e26d541bf5